IP Library Granted Patent US 10,272,201
Granted Patent B2
US 10,272,201 · App. 15/389,246 · Granted Apr 30, 2019

Insertion site monitoring methods and related infusion devices and systems

Inventors: Mikhail Loutseiko (Granada Hills, CA); Anirban Roy (Agoura Hills, CA); Benyamin Grosman (Valley Village, CA); Di Wu (Montrose, CA); Rebecca K. Gottlieb (Culver City, CA); Neha J. Parikh (West Hills, CA)
Assignee: Medtronic MiniMed, Inc.
A61M5/1723A61M5/14244A61M5/16836G16H20/17G16H40/63A61B5/14532A61B5/4839A61M2005/14208A61M2205/50A61M2205/502A61M2205/52A61M2230/201
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,272,201
App. No.
15/389,246
Granted
Apr 30, 2019
Kind
B2
Abstract

Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device involves obtaining one or more measurement values of a physiological condition in the body of a user during an initial monitoring period and determining a fasting reference value for a metric based on the one or more measurement values. After the initial monitoring period, the method continues by obtaining an updated measurement value during a fasting period, determining a current value for the metric based at least in part on the updated measurement value, and generating a notification in response to a deviation between the current value and the fasting reference value exceeding a threshold indicative of insertion site loss or other loss of effectiveness.

Claims (16)

1. A method of operating an infusion device operable to deliver insulin to a body of a patient, the method comprising:

obtaining, from a sensing arrangement, sensed glucose measurement values of a glucose level in the body of the patient during fasting periods during an initial period after initialization of an infusion set associated with the infusion device;

determining a fasting amount of insulin in the body of the patient during the fasting periods;

determining a reference insulin estimate for achieving a reference glucose value based at least in part on the fasting amount of insulin and the sensed glucose measurement values; and

after the initial period:

obtaining, from the sensing arrangement, an updated glucose measurement value during a subsequent fasting period;

determining a current amount of insulin in the body of the patient;

determining a current insulin estimate for achieving the reference glucose value based at least in part on the current amount of insulin and the updated glucose measurement value; and

generating an insertion site notification based on a relationship between the current insulin estimate and the reference insulin estimate.

2. The method of claim 1 , further comprising determining the current amount of insulin based on historical delivery data corresponding to preceding operation of the infusion device to deliver the insulin to the body of the patient.

3. The method of claim 2 , further comprising determining a total daily insulin value based on the historical delivery data, wherein determining the current insulin estimate comprises calculating the current insulin estimate based on the updated glucose measurement value, the reference glucose value, the current amount of insulin, and the total daily insulin value.

4. The method of claim 2 , further comprising verifying the glucose level in the body of the patient is stable prior to obtaining the sensed glucose measurement values.

5. The method of claim 2 , further comprising verifying normal operation of the infusion device prior to obtaining the sensed glucose measurement values.

6. The method of claim 2 , further comprising verifying absence of a meal within a threshold time period prior to obtaining the sensed glucose measurement values.

7. The method of claim 6 , further comprising verifying the glucose level in the body of the patient is stable prior to obtaining the sensed glucose measurement values.

8. The method of claim 1 , further comprising verifying absence of a meal within the threshold time period prior to obtaining the updated glucose measurement value.

Assignments (2)
SECURITY INTEREST Recorded Jan 16, 2026
From: MEDTRONIC MINIMED, INC.; COMPANION MEDICAL, INC.
To: CITIBANK, N.A.
Reel/Frame 074394/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2016
From: LOUTSEIKO, MIKHAIL; ROY, ANIRBAN; GROSMAN, BENYAMIN; WU, DI; GOTTLIEB, REBECCA K.; PARIKH, NEHA J.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 040756/0278 →
Continuity (1)
Related Publication 20180177946A1 · Jun 28, 2018
Cited By (1)
US 12,315,631